Category :   Corporate Information

GEFTINAT 250 — EXCLUSIVE IN UKRAINE NEW GENERATION DRUG USED FOR TREATMENT OF REFRACTORY NON-SMALL CELL LUNG CANCER

№10 2 2008 26

BREAST CANCER HORMONOTHERAPY: CURRENT STATUS OF THE PROBLEM

Authors:Tarutinov V.I. Kovaleva L.Yu. №9 2 2007 9

PREVENTION OF MAMMARY GLAND PATHOLOGY IN PATIENTS WITH UTERUS MYOMA AFTER SURGICAL TREATMENT

Authors:Bugaytsov S.G. Suprun A.E. №9 2 2007 22

MEBIFON — AN EFFECTIVE DOMESTIC BISPHOSPHONIC DRUG

Authors:Pivnyuk V.M. Sharykina N.I. Dekhtyar T.V. Khavych O.O. ... №9 2 2007 18

THE ASSESSMENT OF HER2/NEU GENE MUTATIONAL STATUS IN BREAST CANCER CELLS

Authors:Klymenko S.V. Zakcharceva L.M. №9 3 2007 8

AROMATASE LETROMARA INHIBITOR BIOEQUIVALENCY ASSAY IN VITRO. THE STUDY OF PERMLABILITY OF CACO-2 CELLS TO REGIMENT

Authors:Reznikov A.G. Solov’ev A.I. Baula O.P. Tarasenko L.V. ... №9 1 2007 17

THERAPY OF HORMONE-SENSITIVE PROSTATE CANCER WITH THE USE OF CALUMIDE (BICALUTAMIDE)

Authors:Kaprin A.D. Semin A.V. Kostin A.A. №9 1 2007 20

STUDY OF NAVELBINE IN COMBINATION WITH CISPLATIN IN TREATMENT OF PATIENTS WITH DISSEMINATED NON‑SMALL CELL LUNG CANCER

№9 1 2007 6

IN DIAGNOSTICS OF THE LARGE BOWEL TUMORS

Authors:Nod’ V.F. №8 3 2006 3

EXPERIENCE OF CONSERVATIVE TREATMENT IN CANCER OF PROSTATE GLAND

Authors:Bidovanets Yu. №8 3 2006 1

«1234»